Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. [electronic resource]
Producer: 20080415Description: 41-6 p. digitalISSN:- 0007-0963
- Administration, Cutaneous
- Aged
- Aminoquinolines -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Drug Administration Schedule
- Facial Neoplasms -- drug therapy
- Female
- Humans
- Imiquimod
- Keratosis -- drug therapy
- Male
- Middle Aged
- Neoplasms, Radiation-Induced -- drug therapy
- Patient Compliance
- Skin Neoplasms -- drug therapy
- Treatment Outcome
- Ultraviolet Rays -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.